The Cigna Group - CI STOCK NEWS

Evernorth, a health services subsidiary of Cigna, and Kaiser Permanente announce a five-year collaboration aimed at enhancing access to affordable, high-quality healthcare for Kaiser members. Effective immediately, the partnership allows Kaiser members traveling outside service areas to utilize Cigna's extensive PPO provider network, improving access to urgent and emergency care. Moreover, Evernorth's Accredo specialty pharmacy will become Kaiser’s preferred external pharmacy, promising savings and enhanced services for specialty drug needs.

The Cigna Corporation (NYSE: CI) will announce its first quarter 2022 financial results on May 6, 2022, at 6:30 a.m. ET. A conference call will follow at 8:30 a.m. ET to discuss these results, with call-in numbers provided for domestic and international participants. A replay of the call will be available starting at 12:30 p.m. ET the same day until 11:59 p.m. ET on May 20, 2022. The financial details will also be accessible via the Investor Relations section of Cigna's website.

Cigna Corporation (NYSE:CI) will host its Investor Day on June 3, 2022, in New York City. The event will run from 8:30 a.m. ET to 1:30 p.m. ET, featuring in-depth presentations on corporate strategy and financial targets. A live webcast will be available on Cigna's Investor Relations website, with a replay accessible for four weeks post-event. Cigna is dedicated to enhancing the health and well-being of individuals through integrated health services.

Cigna Corporation (NYSE: CI) announced a strategic plan for capital deployment aimed at enhancing shareholder value, projecting over $12 billion in deployable capital for 2022. This includes $5.4 billion from the sale of its international insurance businesses. The Board approved a $6 billion increase in share repurchase authorization, bringing the total to $10 billion. Cigna plans to allocate more than $7 billion for share repurchases this year, reinforcing confidence in its growth prospects while also approving $450 million for Cigna Ventures to support innovation.

Cigna Corporation (NYSE:CI) announced that CFO Brian Evanko will present at the Barclays Global Healthcare Conference on March 16, 2022, in Miami, FL. The presentation is set to begin at approximately 1:35 p.m. ET. A live webcast will be available on Cigna's investor relations page. Cigna aims to enhance health services globally, maintaining over 185 million customer relationships across more than 30 countries.

Cigna Corporation (NYSE: CI) announced the retirement of John Murabito, long-serving Chief Human Resources Officer and Chief Administrative Officer, effective April 1. Cynthia Ryan, who has been with Cigna for 23 years, has been appointed as the new CHRO. Murabito's leadership was pivotal in developing a strong HR team to support Cigna's 70,000 employees globally. Ryan, a seasoned HR professional, aims to strengthen employee engagement and talent management. This leadership transition is seen as a crucial step in adapting to a changing talent landscape, enhancing Cigna's strategic growth initiatives.

Evernorth, the health services division of Cigna (NYSE: CI), has partnered with Monument to enhance access to alcohol use disorder (AUD) treatment through Monument's virtual platform. This initiative benefits millions of customers, making therapy, medications, and peer support available to Evernorth and Cigna health plan clients in 20 states. Evernorth aims to address the rising alcohol use, reported to have increased for nearly 60% of individuals during the pandemic. Both companies emphasize their commitment to improving health outcomes through innovative, affordable treatment options.

Cigna Corporation (NYSE:CI) announced that Eric Palmer, CEO of Evernorth, will present at the Cowen 42nd Annual Health Care Conference on March 7, 2022. The presentation, starting at 10:30 a.m. ET, will be accessible via a live webcast on Cigna's investor relations page. The company, dedicated to improving health and well-being globally, offers a wide range of health services and maintains customer relationships in over 30 countries.

Accredo, a specialty pharmacy under Evernorth, Cigna's health services arm, has received URAC's Rare Disease Pharmacy Center of Excellence designation. This accreditation highlights Accredo's dedication to quality health services and improved outcomes for patients with rare diseases. With an estimated 25 to 30 million individuals affected by rare diseases in the U.S., Accredo's specialized resources include a team of about 500 pharmacists and 600 nurses, catering to 23 different rare diseases. URAC accreditation indicates excellence in patient care and safety.